Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.53 |
| ▸ | MIF | P14174 | 2/20 | 0.53 |
| ▸ | HTR2A | P28223 | 2/20 | 0.51 |
| ▸ | HTR2B | P41595 | 2/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | ACP3 | P15309 | 1/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30096354 | 1.00 | TAAR1 (0.55) | TAAR1IDO1MIFHTR2AHTR2B | |
| SCHEMBL10978169 | 0.85 | FDFT1 (0.46) | TAAR1IDO1ALDH1A1MAOBNR4A2 | |
| SCHEMBL14109292 | 0.83 | OPRL1 (0.45) | TAAR1IDO1MIFHTR2AHTR2B | |
| SCHEMBL1833487 | 0.81 | MEN1 (0.66) | TAAR1IDO1MIFHTR2AHTR2B | |
| SCHEMBL21021174 | 0.81 | MAOB (0.59) | ACP3KDM4EALDH1A1GAAMMP3 | |
| SCHEMBL3208460 | 0.81 | TAAR1 (0.55) | TAAR1IDO1MIFHTR2AHTR2B | |
| SCHEMBL1758495 | 0.81 | TAAR1 (0.59) | TAAR1IDO1MIFHTR2AHTR2B | |
| SCHEMBL3636560 | 0.81 | MIF (0.62) | TAAR1IDO1MIFHTR2AHTR2B | |
| SCHEMBL9967842 | 0.81 | ENPP2 (0.49) | ENPP2KDM4EMMP3DRD3MEN1 | |
| SCHEMBL624792 | 0.79 | IDO1 (0.47) | TAAR1IDO1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 535 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240363899-A1 | RECHARGEABLE LITHIUM BATTERY | SAMSUNG SDI CO., LTD. (KR) | 2024-10-31 | — | — | US | claimed |
| CN-118231768-A | Electrolyte, sodium ion battery and electric equipment | 比亚迪股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117820169-A | Preparation method of m-trifluoromethyl benzyl cyanide | 上海赫腾精细化工有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117317142-A | Self-polymerization product modified lithium ion solid-state battery anode based on alkali-initiated in-situ nucleophilic reaction, and preparation method and application thereof | 武汉大学 | 2023-12-29 | — | — | CN | claimed |
| CN-117229131-A | Preparation method of 1-phenyl-3- (3-trifluoromethyl phenyl) -2-acetone | 北京颖泰嘉和生物科技股份有限公司 | 2023-12-15 | — | — | CN | claimed |
| EP-4239748-A1 | RECHARGEABLE LITHIUM BATTERY | Samsung SDI Co., Ltd. (KR) | 2023-09-06 | — | — | EP | claimed |
| CN-116478066-A | Production process of m-trifluoromethyl benzyl cyanide | 宁夏思科达生物科技有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-116003253-A | Preparation method of trifluoro-phenylpyrimidine intermediate 2- [3- (trifluoromethyl) phenyl ] dimethyl malonate | 上海试四化学品有限公司 | 2023-04-25 | — | — | CN | claimed |
| US-11634377-B2 | Fenfluramine compositions and methods of preparing the same | ZOGENIX INTERNATIONAL LIMITED (GB) | 2023-04-25 | — | — | US | claimed |
| CN-109097256-B | Microorganism culture device | 上海天信绿色食品有限公司 | 2021-12-21 | — | — | CN | claimed |
| CN-101070278-A | Phenyl-3-(3-trifluoro-methyl-phenyl)-2-propanone | SHANGHAI WANKAI CHEMISTRY CO L (CN) | 2007-11-14 | — | — | CN | claimed |
| CN-1257888-C | Method for synthesizing m-trifluoromethyl benzyl cyanide | SHANGHAI NO 4 REAGENT AND HV C (CN) | 2006-05-31 | — | — | CN | claimed |
| CN-1660789-A | Method for synthesizing m-trifluoromethyl benzyl cyanide | SHISIHEWEI CHEMICAL CO LTD SHA (CN) | 2005-08-31 | — | — | CN | claimed |
| EP-0292816-B1 | PROCESS FOR THE PREPARATION OF META-TRIFLUOROMETHYLPHENYLACETONITRILE | Degussa Aktiengesellschaft (DE) | 1991-07-10 | — | — | EP | claimed |
| US-4824987-A | Method of preparing m-trifluoromethylphenyl acetonitrile | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1989-04-25 | — | — | US | claimed |
| US-4822903-A | Fluorinated silica catalyst and preparation of aromatic/aliphatic nitriles in the presence thereof | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1989-04-18 | — | — | US | claimed |
| EP-0292816-A1 | Process for the preparation of meta-trifluoromethylphenylacetonitrile | Degussa Aktiengesellschaft (DE) | 1988-11-30 | — | — | EP | claimed |
| US-4438042-A | FROM AMIDES, FLUORINATE SILCEOUS CATALYSTS | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-03-20 | — | — | US | claimed |
| US-4436669-A | CYANATION, DECARBONYLATION, ACID CATALYSTS | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-03-13 | — | — | US | claimed |
| US-4307034-A | ALKYLATION | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1981-12-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240363899-A1 | RECHARGEABLE LITHIUM BATTERY | PHOSPHO1, NIBAN2, NUCB2 | TAAR1 1357/4885IDO1 2007/4885MIF 3003/4885 |
| US-11634377-B2 | Fenfluramine compositions and methods of preparing the same | FAAH, FAAH2, TPH1 | TAAR1 243/4885IDO1 134/4885MIF 3466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.